馃嚫馃嚜 Xvivo Perfusion AB
XVIVO.STFundamentals
Gross Margin
65.7%
Op. Margin
11.5%
Net Margin
3.1%
ROIC
3.2%
Rev Growth
-1.2%
Valuation
Price
264.00 SEK
Day
+1.62%
52-Week Range
160.00 - 314.80
Market Cap
8.3B SEK
Fwd P/E
44.7x
EV/EBITDA
50.6x
Div Yield
-
Annual income statement #
Xvivo Perfusion AB annual revenue, operating income and net income in SEK, 2016 to 2025. Revenue was 812.2m in 2025.
| Year | Revenue (SEK) | Operating income | Net income | Net margin |
|---|---|---|---|---|
| 2025 | 812.2m | 93.0m | 25.2m | 3.1% |
| 2024 | 822.4m | 88.4m | 172.2m | 20.9% |
| 2023 | 597.5m | 4.2m | 91.8m | 15.4% |
| 2022 | 415.3m | 23.2m | 18.4m | 4.4% |
| 2021 | 258.4m | 7.0m | 8.2m | 3.2% |
| 2020 | 179.9m | -34.3m | -43.7m | -24.3% |
| 2019 | 220.8m | 5.6m | 4.9m | 2.2% |
| 2018 | 187.9m | 14.0m | 12.7m | 6.8% |
| 2017 | 148.3m | 7.1m | 6.3m | 4.2% |
| 2016 | 138.2m | 2.7m | 1.5m | 1.1% |
Financial Data #
Segment Breakdown #
Peers #
EUZ.DE SNT.WA ELN.MI IBAB.BR REG1V.HE DRW8.DE CEVI.ST EMBLA.CO SBS.DE GN.CO 路
Compare in Screener
Dividends
Bubble
Short Interest #
Current: 5.01% 路
30d ago: 5.61% 路
All-time high: 7.75% (2026-03-27)
Marchant MC Ltd 1.57%
路 JPMorgan Asset Management (UK) Ltd 1.36%
路 Citadel Advisors LLC 0.89%
路 ActusRayPartners Limited 0.60%
路 D E Shaw Co LP 0.59%
Events #
| Date | Type | Details | Price | Amount |
|---|